Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Managing Partnerships with CROs

03 Oct 2012 - 04 Oct 2012 - London, UK



Bookmark and Share


The event offers the unique opportunity to hear from representatives from Pharma, CRO and Academia with an emphasis on improving communication and creating strong and successful partnerships between all parties.

Key benefits of attending:

Learn from industry specialists what current issues are facing those working within sponsor CRO relationships. 

Understand what causes breakdown in relationships and ways to prevent this through real case studies. 

Hear from speakers on both sides of the relationship, and their strategies for developing successful partnership.

Discuss the strategic rationale for clinical development outsourcing among the large pharmaceutical companies

Two highly rated workshops, Peter Volker from Booz & Co the company that recently released a highly rated report with CRO ICON. Dr. Volker will discuss key issues on preparing for partnership and engagement models and success factors and Graeme Ladds who has worked with CROs for many years had developed his workshop to touch upon points for success, strategy for maintaining quality and multinational multiproduct outsourcing.

For more information visit http://www.smi-online.co.uk/goto/pharmaoutsourcingevent9.asp

Or Contact Fateja Begum on fbegum@smi-online.co.uk or tel +44 0 207 827 6184



Further information
Scientific News
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Lynparza Phase III Progression-Free Survival Benefit
AstraZeneca announces results from Phase III SOLO-2 trial designed to determine the efficacy of Lynparza as a monotherapy for ovarian cancer.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!